News
DXCM
64.00
-40.66%
-43.85
DEXCOM OUTLOOK FY REVENUE USD 4,000-4,050 MILLION
Reuters · 1h ago
US STOCKS-Wall St closes up on revival supported by inflation data, tech stocks
Wall St closes up on revival supported by inflation data, tech stocks PCE inflation rises moderately in June Russell 2000, S&P Small Cap 600 gain for fourth day in five Deckers, Baker Hughes, Norfolk Southern climb after results. The Dow Jones Industrial Average ends positive for the week. Inflation data boosted optimism that the Fed will soon start cutting interest rates.
Reuters · 5h ago
BUZZ-U.S. stocks weekly: Rocky
S&P 500 falls second straight week, loses 0.8% in choppy trading. Communication Services most unsteady, while defensive plays and Healthcare are ballasts. Tech retreats 2.4% on the week as chip stocks extend selloff after disappointing earnings.
Reuters · 5h ago
Quiver Markets Close: Wall Street Rallies on Inflation Data
NASDAQ · 5h ago
These Stocks Moved the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More
Barron‘s · 5h ago
US STOCKS-Wall St ends higher on revival supported by inflation data, tech
Major U.S. Indexes close higher on Friday. Dow Jones Industrial Average, S&P 500 and Nasdaq Composite all rise for the week. Investors flock back to tech megacaps after recent sell-offs. Inflation data boosted optimism that interest rate cuts will soon begin.
Reuters · 6h ago
DexCom reaches a multi-year low as downgrades follow guidance cut
Seeking Alpha · 6h ago
DexCom Is Maintained at Buy by BTIG
Dow Jones · 6h ago
DexCom Price Target Cut to $120.00/Share From $156.00 by BTIG
Dow Jones · 6h ago
BTIG Maintains Buy on DexCom, Lowers Price Target to $120
Benzinga · 6h ago
US STOCKS-Dow leads Wall St revival on inflation data, tech stocks rebound
Dow leads Wall St revival on inflation data, tech stocks rebound PCE inflation rises moderately in June Russell 2000 hits one-week high Deckers, Baker Hughes climb after results Dexcom slips after cutting revenue forecast Indexes up: Dow 1.73%, S&P 1.24%, Nasdaq 1.07%. In-line inflation data supports bets that the Fed will cut interest rates in September.
Reuters · 7h ago
S&P 500 Gains Over 1%; 3M Shares Jump After Q2 Results
U.S. Stocks traded higher toward the end of trading on Friday. The Dow traded up 1.66% and the S&P 500 gained more than 1%. 3M Company shares jumped 21% after the company posted better-than-expected second-quarter results. Asian markets closed mostly higher; European shares were also higher.
Benzinga · 7h ago
BUZZ-U.S. STOCKS ON THE MOVE-Hartford Financial, Avantor, WesBanco
Dow Jones Industrial Average was up 2.04% at 1332 ET. Top three S&P 500 percentage gainers: Mohawk Industries, 3M and Charter Communications. The top three Nasdaq percentage losers: Dexcom, Biogen and Allen & Hamilton. Wall Street bounced back on Friday.
Reuters · 8h ago
DexCom Is Maintained at Equal-Weight by Morgan Stanley
Dow Jones · 8h ago
DexCom Price Target Cut to $75.00/Share From $120.00 by Morgan Stanley
Dow Jones · 8h ago
Sector Update: Health Care Stocks Rise in Afternoon Trading
NASDAQ · 8h ago
DexCom’s stock is headed for its worst selloff ever. Not everyone thinks it’s justified.
MarketWatch · 8h ago
Wall Street Enjoys Late-Week Rally On Benign Inflation Data, Dow Jones Eyes Best Session Of 2024, Tech Unwinding Stalls: What's Driving Markets Friday?
The Dow Jones Industrial Average surged 1.9% on Friday. In June, inflation dropped to 2.5% year-on-year, below the Fed's 2% target. The tech-heavy Nasdaq 100 rebounded from a negative weekly close. Homebuilders rose over 3% for the day, reaching all-time highs.
Benzinga · 8h ago
Morgan Stanley Maintains Equal-Weight on DexCom, Lowers Price Target to $75
Benzinga · 8h ago
DXCM INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into DexCom, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. Federal securities laws involving DexCom, Inc. The investigation is focused on whether DexCom and certain of its top executives made false and/or misleading statements to investors. DexCom manufactures and distributes glucose monitoring systems used in treating diabetes.
Barchart · 8h ago
More
Webull provides a variety of real-time DXCM stock news. You can receive the latest news about Dexcom Inc through multiple platforms. This information may help you make smarter investment decisions.
About DXCM
DexCom, Inc. is a medical device company. The Company enables people to take real-time control of health through continuous glucose monitoring (CGM) systems. The Company is engaged in diabetes care technology. Based on the needs of users, caregivers, and providers, the Company works to simplify and improve diabetes management around the world. The Company is primarily focused on the design, development, and commercialization of CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Dexcom Stelo is designed specifically for people with type II diabetes who do not use insulin and are not at risk for hypoglycemia. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device.